OMNITROPE

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Ireland, Lithuania, Netherlands, New Zealand, Poland, Romania, Tunisia, Turkey, United Kingdom, United States

Active ingredients

The drug OMNITROPE contains one active pharmaceutical ingredient (API):

1 Somatropin
UNII NQX9KB6PCL - SOMATROPIN

Somatropin is a potent metabolic hormone of importance for the metabolism of lipids, carbohydrates and proteins. In children with inadequate endogenous growth hormone, somatropin stimulates linear growth and increases growth rate. In adults, as well as in children, somatropin maintains a normal body composition by increasing nitrogen retention and stimulation of skeletal muscle growth, and by mobilization of body fat.

Read about Somatropin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
H01AC01 Somatropin H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AC Somatropin and somatropin agonists
Discover more medicines within H01AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 10446T, 10485W, 10490D, 10506Y, 10507B, 10512G, 10514J, 10518N, 10519P
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 511515080060403, 511518001153415, 511518002151416
Country: CA Health Products and Food Branch Identifier(s): 02325063, 02325071, 02459647
Country: EE Ravimiamet Identifier(s): 1238677, 1238688, 1238699, 1368996, 1369009, 1369021, 1369032, 1369043, 1369054, 1662870, 1662881, 1662892
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 106332010, 106332013, 106332014, 106332016, 106332017
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 066689, 483821, 515191, 540046, 567077
Country: FR Base de données publique des médicaments Identifier(s): 63450352, 64316662, 65086919
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 127952, 232666, 232668, 296804
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1030288, 1030289, 1030290, 1030291, 1030292, 1030293, 1030297, 1030298, 1030299, 1061349, 1061350, 1061351, 1073840, 1073841, 1073842, 1073843, 1073844, 1073845
Country: NL Z-Index G-Standaard, PRK Identifier(s): 53082, 53090, 53104, 80705
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 15952, 15953, 15954
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100160901, 100160999, 100176954, 100180157, 100252081, 100302181, 100302198
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W51608001, W52337001, W52337002, W52345001, W52345002, W52345003, W52346001, W52346002, W52346003, W59825001, W59825002, W59825003, W63193001, W63194001
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 11073021H
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8681428950126, 8681428950133, 8681428950140, 8699516953805, 8699516953812, 8699516953829, 8699516953836, 8699516953843, 8699516953850
Country: US FDA, National Drug Code Identifier(s): 0781-3001, 0781-3004

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.